News

Bill Anderson will stay at the helm of the pharmaceutical company until March 2029, after the supervisory board extended his ...
Germany's Bayer said on Wednesday that its supervisory board had extended the contract of CEO Bill Anderson until March 31, ...
Joining Bayer Leverkusen from Union Berlin in 2021, Robert Andrich is now one of the club’s longest serving players with 153 ...
Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside.
Bayer CEO Bill Anderson has been given more time to restructure the German agricultural chemicals and pharmaceuticals group. Anderson's contract, which was due to expire at the end of March 2026, has ...
Bayer Leverkusen have made an audacious move to sign Barcelona midfielder Marc Casado. According to Fichajes, the German club ...
The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...
The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...
Bayer’s Kerendia (finerenone) has been approved by the US Food and Drug Administration (FDA) to treat heart failure (HF) patients with left ventricular ejection fraction (LVEF) of at least 40%.
Bayer’s BAYRY wholly owned subsidiary, BlueRock Therapeutics, announced that the first patient in the phase I/IIa CLARICO ...
While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...